Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M192,735Revenue (TTM) $M53,244Net Margin (%)11.6Altman Z-Score2.1
Enterprise Value $M222,753EPS (TTM) $0.1Operating Margin %23.5Piotroski F-Score5
P/E(ttm)397Beneish M-Score-2.5Pre-tax Margin (%)13.6Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %2.6Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %1.2Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow15.4y-y EBITDA Growth Rate %-17.6ROA % (ttm)3.6Higher Current Ratio y-yN
Dividend Yield %3.8PEG26.1ROE % (ttm)9.6Less Shares Outstanding y-yY
Payout Ratio %118Shares Outstanding M6,068ROIC % (ttm)11.7Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFERichard Pzena 2016-06-30 Reduce$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -0.03%2,186,404
PFEKeeley Asset Management Corp 2016-06-30 Reduce$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -3.73%100,600
PFERonald Muhlenkamp 2016-06-30 Reduce-0.02%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -3.54%37,049
PFET Rowe Price Equity Income Fund 2016-06-30 Reduce-0.11%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -5.36%13,941,800
PFECharles Brandes 2016-06-30 Reduce-0.13%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -5.51%5,231,096
PFEJoel Greenblatt 2016-06-30 Add0.15%$29.64 - $35.31
($33.58)
$ 31.59-6%Add 22.89%1,938,282
PFENWQ Managers 2016-06-30 Reduce-0.19%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -16.80%2,095,468
PFEJohn Paulson 2016-06-30 Reduce-0.2%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -62.96%510,400
PFEBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.21%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -8.83%48,981,192
PFEVanguard Health Care Fund 2016-06-30 Sold Out -0.48%$29.64 - $35.31
($33.58)
$ 31.59-6%Sold Out0
PFEDavid Dreman 2016-06-30 Add0.52%$29.64 - $35.31
($33.58)
$ 31.59-6%Add 414.81%29,962
PFEDavid Tepper 2016-06-30 Sold Out -1.32%$29.64 - $35.31
($33.58)
$ 31.59-6%Sold Out0
PFEKahn Brothers 2016-06-30 Reduce-1.59%$29.64 - $35.31
($33.58)
$ 31.59-6%Reduce -19.80%1,156,866
PFERuane Cunniff 2016-03-31 Reduce$28.56 - $32.28
($30.14)
$ 31.595%Reduce -16.22%12,442
PFEFirst Eagle Investment 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 31.595%Add 3.98%141,061
PFERichard Pzena 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 31.595%Add 1.18%2,187,104
PFEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.01%$28.56 - $32.28
($30.14)
$ 31.595%Reduce -0.26%53,724,766
PFEDavid Dreman 2016-03-31 Buy 0.02%$28.56 - $32.28
($30.14)
$ 31.595%New holding5,820
PFEKeeley Asset Management Corp 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 31.595%Add 34.41%104,500
PFET Rowe Price Equity Income Fund 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 31.595%Add 1.42%14,730,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JExecutive Vice President 2016-11-09Sell10,000$33-4.27view
BOURLA ALBERTGroup President 2016-11-04Sell18,390$30.055.12view
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.49-8.41view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.97-7.01view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.5-5.7view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.53-5.79view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.66-6.15view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.8-6.54view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.71-6.29view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.84-6.65view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    US Market Indexes Higher on Tuesday Nov 29 2016 
    Small-Cap Biotech Is on Front Lines of Fight Against Depression Nov 22 2016 
    How a 15% Decline Is a Gift to Income Investors Nov 21 2016 
    3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
    Johnson & Johnson Expect it to Deliver Consistent Results Nov 08 2016 
    Allergan: Trading at a Low Earnings Multiple Nov 06 2016 
    US Market Indexes Lower on Tuesday Nov 02 2016 
    Seven New Stocks in My Purloined Portfolio Oct 19 2016 
    Pfizer Refuses to Go the Spinoff Route Oct 17 2016 

    More From Other Websites
    Can't buy love? Drug price hikes put sex beyond reach Dec 05 2016
    Can't buy love? Drug price hikes put sex beyond reach Dec 05 2016
    Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
    Sanofi to Explore Counterbid for Actelion Amid J&J Talks Dec 05 2016
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016
    Pfizer (PFE) Presents Favorable Data on Leukemia Candidate Dec 05 2016
    Pfizer's blood cancer drug Bosulif effective in untreated patients Dec 05 2016
    Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for... Dec 05 2016
    1:57 am Pfizer reports new Phase 2 results show investigational compound Glasdegib; demonstrated... Dec 05 2016
    Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions Dec 03 2016
    New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute... Dec 03 2016
    Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial... Dec 03 2016
    [$$] New Tax Rules on Corporate Inversions Face Uncertain Future Dec 03 2016
    $50 Billion Quant Fund Is Making New Bets On These Stocks Dec 02 2016
    The Numbers Behind a Pharma CEO Shouting Match Dec 02 2016
    Morgan Stanley Wealth Management: Chevron, Pfizer May be Big Winners in 2017 Dec 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)